Ali Kaan Yelbey
Ali Kaan Yelbey has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Gülbahar Tabakoğlu
Izmir Bakircay University
1 shared publication - Helin Avcı1 shared publication
- Rumeysa İnCesu
Izmir Bakircay University
1 shared publication - Tarkan Akderya
İZMİR BAKIRÇAY ÜNİVERSİTESİ
1 shared publication
Latest Publications
- 22 September 2026
- Published by Izmir UOD
- p. 369-376
The Use of Fibre-Reinforced Hybrid Composites in the Biomedical Field
Composites are materials that achieve desired properties by combining different components and are used in various industries. In particular, fibre-reinforced hybrid composites (FRHCs) offer superior mechanical performance and sustainability. FRHCs are advanced engineering materials formed by combining different types of fibres (carbon, glass, aramid, or plant-based fibres) with a matrix material. In the biomedical field, the search for alternative biomaterials to improve the quality of life and reduce the adverse effects of existing metal implants has been accelerating. Due to issues such as low elastic modulus, corrosion risk, and stress accumulation associated with metal implants, there is a need for lighter and more suitable materials. A material intended for biomedical use must possess properties such as biocompatibility, corrosion resistance, elastic modulus, mechanical strength, and stability. FRHCs are being investigated for use in various biomedical engineering fields, including joint prostheses, hip prostheses, bone plates, dental implants, heart valves, contact lenses, vascular grafts, dialysis membranes, catheters, pacemakers, electrodes, and vascular prostheses. However, research continues regarding factors such as long-term biocompatibility assessments, the complexity of the production process, and cost. Researchers are striving to develop polymer-based, high-strength FRHCs specifically designed to offer patients a longer service life and greater lightweight properties. Within the scope of this study, the potential applications, advantages, and limitations of FRHCS in the biomedical field were presented.
- 22 September 2026
- Published by Izmir UOD
- p. 369-376
The Use of Fibre-Reinforced Hybrid Composites in the Biomedical Field
Composites are materials that achieve desired properties by combining different components and are used in various industries. In particular, fibre-reinforced hybrid composites (FRHCs) offer superior mechanical performance and sustainability. FRHCs are advanced engineering materials formed by combining different types of fibres (carbon, glass, aramid, or plant-based fibres) with a matrix material. In the biomedical field, the search for alternative biomaterials to improve the quality of life and reduce the adverse effects of existing metal implants has been accelerating. Due to issues such as low elastic modulus, corrosion risk, and stress accumulation associated with metal implants, there is a need for lighter and more suitable materials. A material intended for biomedical use must possess properties such as biocompatibility, corrosion resistance, elastic modulus, mechanical strength, and stability. FRHCs are being investigated for use in various biomedical engineering fields, including joint prostheses, hip prostheses, bone plates, dental implants, heart valves, contact lenses, vascular grafts, dialysis membranes, catheters, pacemakers, electrodes, and vascular prostheses. However, research continues regarding factors such as long-term biocompatibility assessments, the complexity of the production process, and cost. Researchers are striving to develop polymer-based, high-strength FRHCs specifically designed to offer patients a longer service life and greater lightweight properties. Within the scope of this study, the potential applications, advantages, and limitations of FRHCS in the biomedical field were presented.